PLABS Stock Overview
An investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
PeterLabs Holdings Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.20 |
| 52 Week High | RM 0.24 |
| 52 Week Low | RM 0.17 |
| Beta | 0.88 |
| 1 Month Change | 11.11% |
| 3 Month Change | 5.26% |
| 1 Year Change | -4.76% |
| 3 Year Change | -4.76% |
| 5 Year Change | -4.76% |
| Change since IPO | -16.67% |
Recent News & Updates
Recent updates
Is PeterLabs Holdings Berhad (KLSE:PLABS) Using Too Much Debt?
Dec 20
PeterLabs Holdings Berhad (KLSE:PLABS) Seems To Use Debt Quite Sensibly
Nov 10Is PeterLabs Holdings Berhad (KLSE:PLABS) A Risky Investment?
Jan 28With EPS Growth And More, PeterLabs Holdings Berhad (KLSE:PLABS) Makes An Interesting Case
Nov 10Is Now The Time To Put PeterLabs Holdings Berhad (KLSE:PLABS) On Your Watchlist?
Feb 02
Are PeterLabs Holdings Berhad's (KLSE:PLABS) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Dec 28Are PeterLabs Holdings Berhad's (KLSE:PLABS) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 30Shareholder Returns
| PLABS | MY Pharmaceuticals | MY Market | |
|---|---|---|---|
| 7D | 11.1% | -2.1% | -1.0% |
| 1Y | -4.8% | -2.5% | 10.0% |
Return vs Industry: PLABS underperformed the MY Pharmaceuticals industry which returned -2.5% over the past year.
Return vs Market: PLABS underperformed the MY Market which returned 10% over the past year.
Price Volatility
| PLABS volatility | |
|---|---|
| PLABS Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in MY Market | 10.5% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: PLABS's share price has been volatile over the past 3 months compared to the MY market.
Volatility Over Time: PLABS's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of MY stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Tong Lim | www.peterlabs.com.my |
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally. The company operates in Manufacturing and Trading segments. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements.
PeterLabs Holdings Berhad Fundamentals Summary
| PLABS fundamental statistics | |
|---|---|
| Market cap | RM 55.04m |
| Earnings (TTM) | RM 2.91m |
| Revenue (TTM) | RM 176.95m |
18.9x
P/E Ratio0.3x
P/S RatioIs PLABS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PLABS income statement (TTM) | |
|---|---|
| Revenue | RM 176.95m |
| Cost of Revenue | RM 154.63m |
| Gross Profit | RM 22.31m |
| Other Expenses | RM 19.40m |
| Earnings | RM 2.91m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 12.61% |
| Net Profit Margin | 1.65% |
| Debt/Equity Ratio | 22.3% |
How did PLABS perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield38%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:45 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PeterLabs Holdings Berhad is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yap Huey Chiang | RHB Investment Bank |